Kyu Jun Son, MD

Senior Director of Corporate Development

Kyu Jun Son was appointed the Senior Director of Corporate Development in May 2023. Prior to joining Convergent, he has worked as a Director of New Product Planning at a small biotech focused on immunology. Before that, he served in several positions of increasing responsibility at Sanofi in the Global Oncology group. Most recently, as the Director of Global LIBTAYO® (cemiplimab) Marketing for Basal Cell Carcinoma (BCC), preparing and leading the global launch of LIBTAYO® (cemiplimab) for the basal cell carcinoma indication. Earlier in his career, Dr. Son supported the development of the Sanofi Oncology portfolio in a variety of data analytic and commercial assessment roles for internal and external assets, including new product planning, business development, market research, competitive intelligence, and forecasting.

Dr. Son earned his Bachelor of Arts in Chemistry with a minor in Economics from Vanderbilt University and his Doctor of Medicine (MD) from Tufts University School of Medicine.